GRCE
Grace Therapeutics·NASDAQ
--
--(--)
--
--(--)
6.14 / 10
Outperform
The firm exhibits satisfactory fundamental strength scoring 6.1/10. Supportive aspects: Interest coverage ratio (EBIT / Interest expense) (%) and Revenue-MV, whereas limitations surface in Days sales outstanding. Investment verdict: promising.
Analysis Checks(9/10)
Revenue-MV
Value-0.26
Score3/3
Weight17.04%
1M Return10.54%
Value-0.26
Score3/3
Weight17.04%
1M Return10.54%
Days sales outstanding
Value313.91
Score1/3
Weight-1.87%
1M Return-1.57%
Value313.91
Score1/3
Weight-1.87%
1M Return-1.57%
Net income-Revenue
Value-0.17
Score2/3
Weight13.60%
1M Return8.45%
Value-0.17
Score2/3
Weight13.60%
1M Return8.45%
Interest coverage ratio (EBIT / Interest expense) (%)
Value42.48
Score2/3
Weight-1.36%
1M Return-1.11%
Value42.48
Score2/3
Weight-1.36%
1M Return-1.11%
Asset-MV
Value-0.50
Score3/3
Weight25.20%
1M Return13.15%
Value-0.50
Score3/3
Weight25.20%
1M Return13.15%
Total operating revenue (YoY growth rate %)
Value45.97
Score2/3
Weight1.46%
1M Return1.11%
Value45.97
Score2/3
Weight1.46%
1M Return1.11%
Profit-MV
Value0.46
Score2/3
Weight13.59%
1M Return8.45%
Value0.46
Score2/3
Weight13.59%
1M Return8.45%
PB-ROE
Value-0.43
Score3/3
Weight18.43%
1M Return12.83%
Value-0.43
Score3/3
Weight18.43%
1M Return12.83%
Operating revenue (YoY growth rate %)
Value64.40
Score2/3
Weight0.56%
1M Return0.43%
Value64.40
Score2/3
Weight0.56%
1M Return0.43%
Cash-MV
Value-0.07
Score2/3
Weight13.36%
1M Return8.41%
Value-0.07
Score2/3
Weight13.36%
1M Return8.41%
Revenue-MV
Value-0.26
Score3/3
Weight17.04%
1M Return10.54%
Value-0.26
Score3/3
Weight17.04%
1M Return10.54%
Total operating revenue (YoY growth rate %)
Value45.97
Score2/3
Weight1.46%
1M Return1.11%
Value45.97
Score2/3
Weight1.46%
1M Return1.11%
Days sales outstanding
Value313.91
Score1/3
Weight-1.87%
1M Return-1.57%
Value313.91
Score1/3
Weight-1.87%
1M Return-1.57%
Profit-MV
Value0.46
Score2/3
Weight13.59%
1M Return8.45%
Value0.46
Score2/3
Weight13.59%
1M Return8.45%
Net income-Revenue
Value-0.17
Score2/3
Weight13.60%
1M Return8.45%
Value-0.17
Score2/3
Weight13.60%
1M Return8.45%
PB-ROE
Value-0.43
Score3/3
Weight18.43%
1M Return12.83%
Value-0.43
Score3/3
Weight18.43%
1M Return12.83%
Interest coverage ratio (EBIT / Interest expense) (%)
Value42.48
Score2/3
Weight-1.36%
1M Return-1.11%
Value42.48
Score2/3
Weight-1.36%
1M Return-1.11%
Operating revenue (YoY growth rate %)
Value64.40
Score2/3
Weight0.56%
1M Return0.43%
Value64.40
Score2/3
Weight0.56%
1M Return0.43%
Asset-MV
Value-0.50
Score3/3
Weight25.20%
1M Return13.15%
Value-0.50
Score3/3
Weight25.20%
1M Return13.15%
Cash-MV
Value-0.07
Score2/3
Weight13.36%
1M Return8.41%
Value-0.07
Score2/3
Weight13.36%
1M Return8.41%
Is GRCE undervalued or overvalued?
- GRCE scores 6.14/10 on fundamentals and holds a Discounted valuation at present. Backed by its -6.65% ROE, 0.00% net margin, -7.12 P/E ratio, 0.89 P/B ratio, and 41.76% earnings growth, these metrics solidify its Outperform investment rating.
